ReviewJournal of clinical medicine2019
PARP Inhibitors as a Therapeutic Agent for Homologous Recombination Deficiency in Breast Cancers.
Man Yee T Keung et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
87 papers cite itlatest 60 shown
this paperpooled itcites it